Form 4: LENSAR Director Aimee Weisner Granted Restricted Stock Units as Annual Compensation

LENSAR, Inc. Director Aimee S. Weisner was granted 7,374 restricted stock units (RSUs) as part of her annual compensation, vesting in May 2026.

Summary

• Aimee S. Weisner, a Director of LENSAR, Inc. (LNSR), acquired 7,374 shares of common stock in the form of Restricted Stock Units (RSUs) on May 23, 2025.
• The RSUs were granted at a price of $0, indicating they are compensation rather than a purchase.
• These RSUs represent a contingent right to receive one share of LENSAR, Inc. common stock per RSU.
• The RSUs are scheduled to vest in full on May 23, 2026, contingent upon Ms. Weisner's continued service to the Issuer through that date.
• Settlement of the RSUs will occur upon the earliest of Ms. Weisner's termination of service, a change in control of the Company, or her death or disability.
• The grant is part of the Issuer's non-employee director compensation program, serving as a component of Ms. Weisner's annual compensation for her service.
• Following this transaction, Ms. Weisner beneficially owns a total of 92,947 shares of LENSAR, Inc. common stock.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it represents a routine compensation event that aligns director interests with shareholders, indicating stable corporate governance practices. There are no negative surprises or significant risks disclosed.

Positives

• The grant of Restricted Stock Units (RSUs) to a director aligns their interests with those of the shareholders, as the value of their compensation is tied to the company's stock performance.
• This is a standard practice in corporate governance for compensating non-employee directors, promoting long-term commitment and oversight.

Negatives

• The issuance of new shares upon vesting and settlement of RSUs will result in a minor dilution of existing shareholder equity, though this is a common and expected aspect of equity compensation plans.

Future Outlook

The Restricted Stock Units are set to vest in full on May 23, 2026, contingent on the director's continued service, indicating a future milestone for this equity compensation.

Management Comments

• The RSUs were granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer.

Industry Context

This filing reflects a routine equity compensation grant to a non-employee director, a common practice across publicly traded companies to attract and retain qualified board members and align their long-term interests with shareholders. Such grants are a standard component of director remuneration in the medical technology and ophthalmology sectors, where LENSAR operates.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of RSUs aligns the director's financial interests with the company's stock performance, potentially leading to more focused oversight. However, future settlement of RSUs will result in minor dilution.
• Employees: No direct impact mentioned, but consistent compensation practices for leadership can contribute to overall company stability and morale.

Next Steps

• The 7,374 Restricted Stock Units are scheduled to vest in full on May 23, 2026, subject to the director's continued service.

Key Dates

Keywords

LENSAR Inc., LNSR, Restricted Stock Units, RSUs, Director Compensation, Equity Compensation, SEC Form 4, Insider Transaction, Corporate Governance